Home › Funds › Nan Fung Group Holdings Ltd › RANI

Nan Fung Group Holdings Ltd position in RANI

Rani Therapeutics Holdings Inc · Health Care

Nan Fung Group Holdings Ltd reported holding 493,584 shares of RANI (Rani Therapeutics Holdings Inc) in its Q3 2026 13F filing — a position valued at US$390K, representing 0.26% of its reported portfolio and ranking #26 among its reported holdings. Nan Fung Group Holdings Ltd has disclosed RANI holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)493.58K sh
Reported value held$390.43K
Portfolio Weight0.26%
First reportedQ3 2023
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Nan Fung Group Holdings Ltd's RANI position evolved

Nan Fung Group Holdings Ltd first disclosed a stake in RANI in Q3 2023 at 493,584 shares (US$1.1M). The position peaked in Q2 2024 at 493,584 shares, worth US$1.9M. Across 13 filings, Nan Fung Group Holdings Ltd held the position steady without any share-count change. The most recent filing (Q3 2026) shows 493,584 shares valued at US$390K.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 493.58K $1.07M New
Q4 2023 493.58K $1.64M Hold
Q1 2024 493.58K $1.54M Hold
Q2 2024 493.58K $1.88M Hold
Q3 2024 493.58K $1.07M Hold
Q4 2024 493.58K $676.21K Hold
Q1 2025 493.58K $621.92K Hold
Q2 2025 493.58K $253.65K Hold
Q3 2025 493.58K $246.69K Hold
Q4 2025 493.58K $666.34K Hold
Q1 2026 493.58K $362.69K Hold
Q2 2026 493.58K $375.32K Hold
Q3 2026 493.58K $390.43K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RANI and 13F data

RANI (Rani Therapeutics Holdings Inc) is a Health Care company. 32 other funds we track also report a position in RANI — the largest reported positions include Samsara BioCapital, LLC (US$7.9M), AWM Investment Company, Inc. (US$5.9M), SymBiosis Capital Partners, LLC (US$2.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RANI

All RANI fund holders →

FAQ

How long has Nan Fung Group Holdings Ltd held RANI?

Nan Fung Group Holdings Ltd has disclosed RANI holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Nan Fung Group Holdings Ltd's current position in RANI?

As of Q3 2026, Nan Fung Group Holdings Ltd holds 493.58K shares of RANI (Rani Therapeutics Holdings Inc), valued at $390.43K, representing 0.26% of its reported portfolio and ranking #26.

Has Nan Fung Group Holdings Ltd been buying or selling RANI?

In the latest 13F filing (Q3 2026), Nan Fung Group Holdings Ltd held unchanged its position in RANI. The position peaked in Q2 2024 at 493.58K shares.

Which other funds hold RANI?

Other major institutional holders of RANI include Samsara BioCapital, LLC, AWM Investment Company, Inc., SymBiosis Capital Partners, LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.